Suppr
超能文献

PD-1 and CTLA4: Two checkpoints, one pathway?

作者信息

Walker Lucy S K

机构信息

Institute of Immunity & Transplantation, University College London Division of Infection & Immunity, Royal Free Campus, London, UK NW3 2PF.

出版信息

Sci Immunol. 2017 May 12;2(11). doi: 10.1126/sciimmunol.aan3864.

DOI:10.1126/sciimmunol.aan3864

PMID:28529997

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5436606/

Abstract

摘要

相似文献

PD-1 and CTLA4: Two checkpoints, one pathway?

Sci Immunol. 2017 May 12;2(11). doi: 10.1126/sciimmunol.aan3864.

Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model.

Vaccines (Basel). 2020 Nov 24;8(4):703. doi: 10.3390/vaccines8040703.

Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.

Urol Oncol. 2017 May;35(5):257-263. doi: 10.1016/j.urolonc.2017.01.014. Epub 2017 Mar 11.

[Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].

Arkh Patol. 2024;86(2):6-13. doi: 10.17116/patol2024860216.

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.

Nature. 2015 Apr 16;520(7547):373-7. doi: 10.1038/nature14292. Epub 2015 Mar 9.

Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1 Activated T Cells.

Cancer Discov. 2021 May;11(5):1100-1117. doi: 10.1158/2159-8290.CD-20-1445. Epub 2021 Jan 8.

Tumour cell-intrinsic CTLA4 regulates PD-L1 expression in non-small cell lung cancer.

J Cell Mol Med. 2019 Jan;23(1):535-542. doi: 10.1111/jcmm.13956. Epub 2018 Oct 30.

Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment.

Front Oncol. 2021 Jul 14;11:720125. doi: 10.3389/fonc.2021.720125. eCollection 2021.

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival.

Cancer Immunol Immunother. 2021 Jul;70(7):2009-2021. doi: 10.1007/s00262-020-02843-x. Epub 2021 Jan 8.

Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study.

Front Immunol. 2020 Sep 10;11:2048. doi: 10.3389/fimmu.2020.02048. eCollection 2020.

引用本文的文献

Costimulatory connections: CARMIL2 and CD28.

J Exp Med. 2025 Aug 4;222(8). doi: 10.1084/jem.20250896. Epub 2025 Jun 20.

LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy.

J Biomed Sci. 2023 Jul 31;30(1):60. doi: 10.1186/s12929-023-00952-0.

PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis.

Front Immunol. 2023 Mar 7;14:997376. doi: 10.3389/fimmu.2023.997376. eCollection 2023.

Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood.

Immunother Adv. 2023 Jan 6;3(1):ltad001. doi: 10.1093/immadv/ltad001. eCollection 2023.

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges.

Front Oncol. 2021 Oct 22;11:737497. doi: 10.3389/fonc.2021.737497. eCollection 2021.

Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity.

Commun Biol. 2021 Sep 28;4(1):1137. doi: 10.1038/s42003-021-02657-2.

Using Machine Learning Modeling to Explore New Immune-Related Prognostic Markers in Non-Small Cell Lung Cancer.

Front Oncol. 2020 Oct 30;10:550002. doi: 10.3389/fonc.2020.550002. eCollection 2020.

Transcriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?

Cancers (Basel). 2020 Oct 30;12(11):3194. doi: 10.3390/cancers12113194.

Targeting co-stimulatory molecules in autoimmune disease.

Nat Rev Drug Discov. 2020 Dec;19(12):860-883. doi: 10.1038/s41573-020-0081-9. Epub 2020 Sep 16.

Exhausted CD4 T Cells during Malaria Exhibit Reduced mTORc1 Activity Correlated with Loss of T-bet Expression.

J Immunol. 2020 Sep 15;205(6):1608-1619. doi: 10.4049/jimmunol.2000450. Epub 2020 Aug 17.

本文引用的文献

Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes.

Sci Immunol. 2016 Nov;1(5). doi: 10.1126/sciimmunol.aai7793. Epub 2016 Nov 18.

Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.

Science. 2017 Mar 31;355(6332):1423-1427. doi: 10.1126/science.aaf0683. Epub 2017 Mar 9.

T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.

Science. 2017 Mar 31;355(6332):1428-1433. doi: 10.1126/science.aaf1292. Epub 2017 Mar 9.

The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness.

Sci Immunol. 2016 Dec 23;1(6). doi: 10.1126/sciimmunol.aai8593. Epub 2016 Dec 9.

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.

Nature. 2016 Sep 15;537(7620):417-421. doi: 10.1038/nature19330. Epub 2016 Aug 2.

Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.

Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):8490-5. doi: 10.1073/pnas.1608873113. Epub 2016 Jul 7.

Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.

J Exp Med. 2012 Jun 4;209(6):1201-17. doi: 10.1084/jem.20112741. Epub 2012 May 28.

The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.

Nat Rev Immunol. 2011 Nov 25;11(12):852-63. doi: 10.1038/nri3108.

Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation.

Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13756-61. doi: 10.1073/pnas.0706509104. Epub 2007 Aug 16.

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13866-71. doi: 10.1073/pnas.231486598. Epub 2001 Nov 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

PD-1 and CTLA4: Two checkpoints, one pathway?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译